Evidence map›Paper›PMID 11836403›Full record

ArticleJournal of virology2002

trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.

Andrew C S Saphire, Michael D Bobardt, Philippe A Gallay

Abstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Reconstitution of retroviral fusion and uncoating in a cell-free system.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew C S SaphireDepartment of Immunology, The Scripps Research Institute, 10550 Torrey Pines Road, La Jolla, California 92037, USA.
Michael D Bobardt
Philippe A Gallay

Funding

ROLE OF CYCLOPHILIN A IN THE HIV-1 LIFE CYCLER01AI046958 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI GALLAY, PHILIPPE ANDRE · 2001 to 2003
$770k
ROLE OF CYCLOPHILIN A IN THE HIV-1 LIFE CYCLER21AI046958 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI GALLAY, PHILIPPE ANDRE · 2000 to 2000
$305k
NIAID NIH HHS AI 46958NIAID NIH HHS R01 AI046958NIAID NIH HHS R21 AI046958
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) requires the incorporation of cyclophilin A (CypA) for replication. CypA is packaged by binding to the capsid (CA) region of Gag. This interaction is disrupted by cyclosporine (CsA). Preventing CypA incorporation, either by mutations in the binding region of CA or by the presence of CsA, abrogates virus infectivity. Given that CypA possesses an isomerase activity, it has been proposed that CypA acts as an uncoating factor by destabilizing the shell of CA that surrounds the viral genome. However, because the same domain of CypA is responsible for both its isomerase activity and its capacity to be packaged, it has been challenging to determine if isomerase activity is required for HIV-1 replication. To address this issue, we fused CypA to viral protein R (Vpr), creating a Vpr-CypA chimera. Because Vpr is packaged via the p6 region of Gag, this approach bypasses the interaction with CA and allows CypA incorporation even in the presence of CsA. Using this system, we found that Vpr-CypA rescues the infectivity of viruses lacking CypA, either produced in the presence of CsA or mutated in the CypA packaging signal of CA. Furthermore, a Vpr-CypA mutant which has no isomerase activity and no capacity to bind to CA also rescues HIV-1 replication. Thus, this study demonstrates that the isomerase activity of CypA is not required for HIV-1 replication and suggests that the interaction of the catalytic site of CypA with CA serves no other function than to incorporate CypA into viruses.

Indexed as

Genetic Complementation TestVirus ReplicationCell LineCyclophilin AGene Products, vprHeLa CellsHIV-1HIV InfectionsHumansIsomerasesMutationRecombinant Fusion ProteinsTransfectionVirus Assemblyvpr Gene Products, Human Immunodeficiency VirusCyclophilin AGene Products, vprIsomerasesRecombinant Fusion Proteinsvpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID11836403
PMCPMC135933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.